Dimethyl Fumarate Promotes the Survival of Retinal Ganglion Cells after Optic Nerve Injury, Possibly through the Nrf2/HO-1 Pathway
This study aimed to verify whether dimethyl fumarate (DMF) promotes the survival of retinal ganglion cells (RGCs) after optic nerve crush (ONC) accompanied by activation of the NF-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. We examined changes in the densities of tubulin β3 (TUBB3)-p...
Main Authors: | Sotaro Mori, Takuji Kurimoto, Hidetaka Maeda, Makoto Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/1/297 |
Similar Items
-
Dimethyl Fumarate as Potential Treatment for Alzheimer’s Disease: Rationale and Clinical Trial Design
by: Robert Sharkus, et al.
Published: (2023-05-01) -
Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023-07-01) -
Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate Structure
by: Valeria Sorrenti, et al.
Published: (2020-12-01) -
Effect of dimethyl fumarate on heme oxygenase-1 expression in experimental allergic encephalomyelitis in rats
by: Kaja Kasarełło, et al.
Published: (2017-12-01) -
Effects of dimethyl fumarate on neuroprotection and immunomodulation
by: Albrecht Philipp, et al.
Published: (2012-07-01)